Science & Enterprise subscription

Follow us on Twitter

  • A company developing messenger RNA therapeutics on demand from single-use biochips is raising $60 million in its se… https://t.co/gNxQafjlOS
    about 9 hours ago
  • New post on Science and Enterprise: Chip-Based RNA Biotech Raises $60M in Venture Funds https://t.co/rHXkiX4vH7 #Science #Business
    about 9 hours ago
  • An easy-to-use device for measuring intraocular pressure responsible for glaucoma is in development by University o… https://t.co/XNVgZXtsw9
    about 13 hours ago
  • New post on Science and Enterprise: Home Eye Pressure Gauge in the Works https://t.co/5OETI9igDD #Science #Business
    about 13 hours ago
  • A biotechnology company is sponsoring university research on light waves reacting in characteristic patterns for de… https://t.co/RG11kdD0as
    about 1 day ago

Please share Science & Enterprise

Covid-19 Vaccines, Therapies – 13 July 2020

Covid-19 vaccine and therapy tracker

This week’s report shows a marked increase in activity on therapies, while the number of vaccines in development and clinical trials increased only slightly. . . . → Read More: Covid-19 Vaccines, Therapies – 13 July 2020

Cannabis Assessed for Pain in Real-World Trial

Cannabis plant

A clinical trial in Canada is evaluating medical cannabis products as treatments for chronic pain with participants reporting their experiences online. . . . → Read More: Cannabis Assessed for Pain in Real-World Trial

Covid-19 Vaccines, Therapies – 6 July 2020

Covid-19 vaccine and therapy tracker.

A continuing feature on Science & Enterprise is a weekly status report of vaccines and therapies for Covid-19 by the scientific illustration software company BioRender. . . . → Read More: Covid-19 Vaccines, Therapies – 6 July 2020

Covid-19 Vaccines, Therapies – 29 June 2020

Vaccine and therapy tracker

We’re following advances in Covid-19 vaccines and therapies with the help of a tracking service created by BioRender, a scientific illustration software company. . . . → Read More: Covid-19 Vaccines, Therapies – 29 June 2020

Covid-19 Antibody Therapy Trial Underway

SARS-Cov-2 viruses

A clinical trial of neutralizing antibodies to treat Covid-19 infections began testing the therapy with hospitalized patients in New York and Los Angeles. . . . → Read More: Covid-19 Antibody Therapy Trial Underway

Antibody Drug Biotech Raises $105M in Venture Funds

Human B-cell

A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round. . . . → Read More: Antibody Drug Biotech Raises $105M in Venture Funds

Biotech Gains Antibody Discovery, Manufacturing Funds

Global Covid-19

A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics. . . . → Read More: Biotech Gains Antibody Discovery, Manufacturing Funds

Trial to Test Convalescent Antibodies for Covid-19

SARS-Cov-2 virus

A group of Canadian academic labs and hospitals will begin a clinical trial testing antibodies from recovered Covid-19 patients as a treatment for the disease. . . . → Read More: Trial to Test Convalescent Antibodies for Covid-19

Univ. Labs Design, Produce Medical Face Shields

McGill face shield

University engineering and medical groups designed simple, open-source face shields for health care workers on the front lines against the Covid-19 pandemic. . . . → Read More: Univ. Labs Design, Produce Medical Face Shields

Simple, Inexpensive Ventilator Developed [Updated]

Automated BVM device

An engineering team created a simple automated ventilator with easy-to-make and available parts to help people in respiratory distress keep breathing. . . . → Read More: Simple, Inexpensive Ventilator Developed [Updated]